tiprankstipranks

Myriam Mendila Insider Profile

4 Followers
Myriam Mendila, Chief Development Officer at CureVac, holds ― shares in CureVac (Ticker: CVAC).
tipranks
Myriam  Mendila

Myriam Mendila
CureVac (CVAC)
Chief Development Officer

Not Ranked
Myriam Mendila has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Myriam Mendila does not currently own shares as a corporate insider.
A breakdown of Myriam Mendila's holdings

Insider Roles

CureVac
(CVAC)
Chief Development Officer
Roles that Myriam Mendila holds in companies

Most Profitable Insider Trade

Stock:
CureVac
(CVAC)
Rating:Informative Sell
Date:Jan 06, 2024 - Today
Return:+28.50%
The most profitable trade made by Myriam Mendila

Myriam Mendila's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CureVac
Jan 06, 2024
Chief Development Officer
Uninformative Buy
Success Rate for
CVAC
1 out of 1 profitable transactions on
CVAC
100%
Average Return for
CVAC
Average return per transaction on
CVAC
+28.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 06, 2024
Uninformative Buy
$0.00
-
$0.00
Jan 06, 2024
Informative Sell
$21.03K
-
$4.22
+28.50%
List of latest transactions for each holding click on a transaction to see Myriam Mendila's performance on stock

Myriam Mendila insider profile FAQ

What is the percentage of profitable transactions made by Myriam Mendila?
The percentage of profitable transactions made by Myriam Mendila is ―.
    What is the average return per transaction made by Myriam Mendila?
    The average return per transaction made by Myriam Mendila is ―.
      What stocks does Myriam Mendila hold?
      Myriam Mendila holds: CVAC stocks.
        What was Myriam Mendila’s latest transaction?
        Myriam Mendila latest transaction was an Uninformative Buy of ―.
          What was Myriam Mendila's most profitable transaction?
          Myriam Mendila’s most profitable transaction was an Informative Sell of CVAC stock on January 6, 2024. The return on the trade was 28.50%.
            What is Myriam Mendila's role in CureVac?
            Myriam Mendila's role in CureVac is Chief Development Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.